ES2501367A2 - Método de tratamiento de coccidiosis - Google Patents

Método de tratamiento de coccidiosis Download PDF

Info

Publication number
ES2501367A2
ES2501367A2 ES201430840A ES201430840A ES2501367A2 ES 2501367 A2 ES2501367 A2 ES 2501367A2 ES 201430840 A ES201430840 A ES 201430840A ES 201430840 A ES201430840 A ES 201430840A ES 2501367 A2 ES2501367 A2 ES 2501367A2
Authority
ES
Spain
Prior art keywords
coccidiosis
treatment
translation
machine
legally binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES201430840A
Other languages
English (en)
Other versions
ES2501367R1 (es
ES2501367B1 (es
Inventor
Carmen NOGAREDA BURCH
José Antonio MORENO MARTÍNEZ
Eduardo ANGULO ASENSIO
Paul Christou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CENTRE DE RECERCA EN AGROTECNOLOGIA-AGROTECNIO
CT DE RECERCA EN AGROTECNOLOGIA AGROTECNIO
Institucio Catalana de Recerca i Estudis Avancats ICREA
Universitat de Lleida
Original Assignee
CENTRE DE RECERCA EN AGROTECNOLOGIA-AGROTECNIO
CT DE RECERCA EN AGROTECNOLOGIA AGROTECNIO
Institucio Catalana de Recerca i Estudis Avancats ICREA
Universitat de Lleida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CENTRE DE RECERCA EN AGROTECNOLOGIA-AGROTECNIO, CT DE RECERCA EN AGROTECNOLOGIA AGROTECNIO, Institucio Catalana de Recerca i Estudis Avancats ICREA, Universitat de Lleida filed Critical CENTRE DE RECERCA EN AGROTECNOLOGIA-AGROTECNIO
Priority to ES201430840A priority Critical patent/ES2501367B1/es
Publication of ES2501367A2 publication Critical patent/ES2501367A2/es
Publication of ES2501367R1 publication Critical patent/ES2501367R1/es
Priority to PCT/ES2015/070435 priority patent/WO2015185779A1/es
Application granted granted Critical
Publication of ES2501367B1 publication Critical patent/ES2501367B1/es
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/179—Colouring agents, e.g. pigmenting or dyeing agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C12N15/825—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving pigment biosynthesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Genetics & Genomics (AREA)
  • Polymers & Plastics (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Otolaryngology (AREA)
  • Medical Informatics (AREA)
  • Birds (AREA)
  • Wood Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Botany (AREA)
  • Pulmonology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)

Abstract

La presente invención se relaciona con el uso de una planta de maíz enriquecida en antioxidantes o un derivado de la misma, para la fabricación de un medicamento, composición nutritiva o nutracéutico para la prevención o tratamiento de coccidiosis, pododermatitis o úlceras en un sujeto. Asimismo, la invención se relaciona con una composición que comprende una parte de una planta de maíz enriquecida en antioxidantes o un derivado de la misma y un agente anticoccídico y con el uso de dicha composición para la prevención o tratamiento de pododermatitis o úlceras asociadas a coccidiosis en un sujeto. La invención también se relaciona con el uso de una parte de una planta de maíz enriquecida en antioxidantes o un derivado de la misma para la obtención de una composición nutritiva o nutracéutico y con una composición nutritiva o nutracéutico que comprende una parte de una planta de maíz enriquecida en antioxidantes o un derivado de la misma.

Description

imagen1
imagen2
imagen3
imagen4
imagen5
imagen6
imagen7
imagen8
imagen9
imagen10
imagen11
imagen12
imagen13
imagen14
imagen15
imagen16
imagen17
imagen18
imagen19
imagen20
imagen21
imagen22
imagen23
imagen24
imagen25
imagen26
imagen27
imagen28
imagen29
imagen30
imagen31
imagen32

Claims (1)

  1. imagen1
    imagen2
    imagen3
    imagen4
    imagen5
    imagen6
ES201430840A 2014-06-02 2014-06-02 Método de tratamiento de coccidiosis Expired - Fee Related ES2501367B1 (es)

Priority Applications (2)

Application Number Priority Date Filing Date Title
ES201430840A ES2501367B1 (es) 2014-06-02 2014-06-02 Método de tratamiento de coccidiosis
PCT/ES2015/070435 WO2015185779A1 (es) 2014-06-02 2015-06-02 Método de tratamiento de coccidiosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201430840A ES2501367B1 (es) 2014-06-02 2014-06-02 Método de tratamiento de coccidiosis

Publications (3)

Publication Number Publication Date
ES2501367A2 true ES2501367A2 (es) 2014-10-01
ES2501367R1 ES2501367R1 (es) 2015-02-18
ES2501367B1 ES2501367B1 (es) 2015-11-10

Family

ID=51610467

Family Applications (1)

Application Number Title Priority Date Filing Date
ES201430840A Expired - Fee Related ES2501367B1 (es) 2014-06-02 2014-06-02 Método de tratamiento de coccidiosis

Country Status (2)

Country Link
ES (1) ES2501367B1 (es)
WO (1) WO2015185779A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023114315A1 (en) * 2021-12-17 2023-06-22 Quality Technology International, Inc. Method and composition for treating parasites in an animal

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3616279A1 (de) * 1986-05-14 1987-11-19 Hoechst Ag Coccidiozide mittel
EP1528104A1 (en) 2003-11-03 2005-05-04 Biogemma MEG1 endosperm-specific promoters and genes
NL1025632C2 (nl) * 2004-03-04 2005-09-07 Cehave Landbouwbelang Voeders Voederkorrels op basis van natuurlijke materialen evenals een werkwijze voor de bereiding hiervan.
ES2340119B1 (es) * 2008-01-18 2011-04-26 Universitat De Lleida Metodo para crear una poblacion combinatoria de plantas transgenicas que expresan y acumulan una diversidad de metabolitos valiosos.
CN101757010A (zh) * 2008-10-31 2010-06-30 苏州科牧动物药品有限公司 用于防治家禽球虫病的药物
CN102370060B (zh) * 2011-09-24 2013-01-02 长治市雄丰清真养殖屠宰有限公司 防治牛羊球虫病的饲料
CN103583886B (zh) * 2013-10-22 2015-11-18 王四荣 一种防止球虫病的雏鸡饲料

Also Published As

Publication number Publication date
WO2015185779A1 (es) 2015-12-10
ES2501367R1 (es) 2015-02-18
ES2501367B1 (es) 2015-11-10

Similar Documents

Publication Publication Date Title
NI201600071A (es) Compuestos de inhibidor de autotaxina
BR112017008659A2 (pt) ?métodos e compostos de agonista de gip?
UA116648C2 (uk) Фумарати як проліки та їх застосування при лікуванні різних захворювань
ECSP17013903A (es) Protein kinase c inhibitors and methods of their use
PH12016502291A1 (en) Indolizine derivatives as phosphoinositide 3-kinases inhibitors
MX2015009058A (es) Composiciones y metodos para tratar la inflamacion cronica y las enfermedades inflamatorias.
CL2016001587A1 (es) Derivado basado en 1,2-naftoquinona y método de preparación del mismo.
JOP20200230A1 (ar) ناهضات ppar (مستقبل ناشر بيروكسيزوم منشط)، ومركبات، ومكونات أدوية، وطرق استعمالها
MY181602A (en) Isochromene derivatives as phosphoinositide 3-kinases inhibitors
NI201600070A (es) Inhibidores tetracíclicos de autotaxina
MX2017013137A (es) Derivados de cromeno como inhibidores de las fosfoinositido-3-cina sas.
MX2017001352A (es) Derivados de pirrolidinona como inhibidores de metionina aminopeptidasa 2 (metap-2).
EA201790726A1 (ru) Фармацевтическая композиция для лечения язвенного колита
EA201691918A1 (ru) Фармацевтические составы ингибитора киназ семейства raf, способы их получения и способы их применения
MX2018000264A (es) Formulaciones topicas de diacereina de rheina y sus usos.
MX364859B (es) Derivados de imidazopirazinona.
JO3372B1 (ar) مشتقات 5-بنزيل إيزوكينولين لعلاج أمراض القلب والأوعية الدموية
WO2015179823A3 (en) Lung localized inhibitors of alpha(v)beta 6
PH12017501735A1 (en) Novel heterocyclic compound, method for preparing the same, and pharmaceutical composition comprising the same
MX2020006075A (es) Composiciones farmaceuticas de bendamustina.
ES2501367A2 (es) Método de tratamiento de coccidiosis
PH12017500323A1 (en) P38 map kinase inhibiting indanyl urea compounds
BR112016026422A2 (pt) solução farmacêutica compreendendo dopamina para uso no tratamento da doença de parkinson
PH12020500472A1 (en) Autotaxin inhibitor compounds
MX369393B (es) Derivados de ftalazina.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 2501367

Country of ref document: ES

Kind code of ref document: B1

Effective date: 20151110

FD2A Announcement of lapse in spain

Effective date: 20231026